CLINICAL_TRIALS
trial_result
· 2021-04-13
Clinical Trial Update: Trimodality Management of T1b Esophageal Cancers [Phase 1, Phase 2]
Summary
A completed Phase 1/2 trial assessing trimodality management for T1b esophageal cancers; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-13